Free Trial

NRx Pharmaceuticals (NRXPW) Competitors

$0.09 +0.00 (+3.09%)
As of 07/18/2025 11:07 AM Eastern

NRXPW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALA

Should you be buying NRx Pharmaceuticals stock or one of its competitors? The main competitors of NRx Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

NRx Pharmaceuticals vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and NRx Pharmaceuticals (NASDAQ:NRXPW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled NRx Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
NRx Pharmaceuticals Neutral

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
NRx Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
NRx PharmaceuticalsN/AN/AN/AN/AN/A

Summary

180 Life Sciences and NRx Pharmaceuticals tied by winning 0 of the 0 factors compared between the two stocks.

Get NRx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for NRXPW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NRXPW vs. The Competition

MetricNRx PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$129.13M$5.52B$9.40B
Dividend YieldN/A3.74%4.00%4.04%
P/E RatioN/A3.5928.2519.77
Price / SalesN/A4,198.65411.1088.91
Price / CashN/A13.1924.9928.17
Price / BookN/A37.888.095.69
Net IncomeN/A-$90.99M$3.25B$257.97M
7 Day PerformanceN/A0.37%0.36%1.92%
1 Month PerformanceN/A5.16%7.70%12.82%
1 Year PerformanceN/A167.70%32.74%19.22%

NRx Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NRXPW
NRx Pharmaceuticals
N/A$0.09
+3.1%
N/A+20.8%$0.00N/A0.00N/AGap Up
ATNFW
180 Life Sciences
N/A$0.01
+2.7%
N/A-16.4%$0.00N/A0.007Gap Up
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.18
+5.9%
N/A+157.1%$0.00$106.21K0.0040Gap Down
ALVOW
Alvotech
N/A$1.80
+13.2%
N/A-33.7%$0.00$585.60M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.04
+75.5%
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
+2.9%
N/AN/A$0.00$38.00M0.0070Gap Up
BTMDW
biote
N/A$0.01
+16.1%
N/AN/A$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.04
-4.6%
N/A-71.5%$0.00N/A0.008Gap Down
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-99.0%$0.00N/A0.0060

Related Companies and Tools


This page (NASDAQ:NRXPW) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners